Remodelling the extracellular matrix in development and disease

Nature Reviews Molecular Cell Biology

Volumn 15, Issue 12, 2014, Pages 786-801

  Bonnans, Caroline ^a,b   Chou, Jonathan ^a,c   Werb, Zena ^a  

^a University of Californias   (United States)

^b INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMALYSIN; ENZYME; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MEPRIN; METALLOPROTEINASE INHIBITOR; PROTEINASE; UNCLASSIFIED DRUG;

BRANCHING MORPHOGENESIS; CANCER CELL; CANCER GROWTH; CELL MIGRATION; EXTRACELLULAR MATRIX; FIBROSIS; INTESTINE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MORPHOGENESIS; ORGANOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VERTEBRATE; ANIMAL; CHEMISTRY; ENZYMOLOGY; EPITHELIUM CELL; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ENDOPEPTIDASES; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; MORPHOGENESIS; NEOPLASMS;

EID: 84922333220     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3904     Document Type: Review

References (161)

1. Hynes R. O. The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219 (2009
2. Jarvelainen H., Sainio A., Koulu M., Wight T. N. & Penttinen R. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol. Rev. 61, 198-223 (2009
3. Bateman J. F., Boot-Handford R. P. & Lamande S. R. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nature Rev. Genet. 10, 173-183 (2009
4. Rozario T. & DeSimone D. W. The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 341, 126-140 (2010
5. Hynes R. O. & Naba A. Overview of the matrisome- an inventory of extracellular matrix constituents and functions. Cold Spring Harb. Perspect. Biol. 4, a004903 (2012
6. Lu P., Takai K., Weaver V. M. & Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol. 3, a005058 (2011
7. Frantz C., Stewart K. M. & Weaver V. M. The extracellular matrix at a glance. J. Cell Sci. 123, 4195-4200 (2010
8. Zhen G. & Cao X. Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol. Sci. 35, 227-236 (2014
9. Gross J. & Lapiere C. M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl Acad. Sci. USA 48, 1014-1022 (1962
10. Hite L. A., Shannon J. D., Bjarnason J. B. & Fox J. W. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal zymogen and disintegrin-like structures. Biochemistry 31, 6203-6211 (1992
11. Kuno K., et al. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 272, 556-562 (1997
12. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nature Rev. Cancer 8, 929-941 (2008
13. White J. M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15, 598-606 (2003
14. Apte S. S. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J. Biol. Chem. 284, 31493-31497 (2009
15. Bond J. S., Rojas K., Overhauser J., Zoghbi H. Y. & Jiang W. The structural genes MEP1A and MEP1B, for the α and β subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively. Genomics 25, 300-303 (1995
16. Bertenshaw G. P., Norcum M. T. & Bond J. S. Structure of homo- and hetero-oligomeric meprin metalloproteases. Dimers tetramers and high molecular mass multimers. J. Biol. Chem. 278, 2522-2532 (2003
17. Herzog C., Haun R. S., Ludwig A., Shah S. V. & Kaushal G. P. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. J. Biol. Chem. 289, 13308-13322 (2014
18. Kruse M. N., et al. Human meprin α and β homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem. J. 378, 383-389 (2004
19. Broder C., et al. Metalloproteases meprinα and meprinβ are C- and N procollagen proteinases important for collagen assembly and tensile strength. Proc. Natl Acad. Sci. USA 110, 14219-14224 (2013
20. Jefferson T., et al. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10. Cell. Mol. Life Sci. 70, 309-333 (2013
21. Geurts N., et al. Meprins process matrix metalloproteinase 9 (MMP 9)/gelatinase B and enhance the activation kinetics by MMP 3. FEBS Lett. 586, 4264-4269 (2012
22. Khokha R., Murthy A. & Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nature Rev. Immunol. 13, 649-665 (2013
23. Baker A. H., Edwards D. R. & Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727 (2002
24. Smith H. W. & Marshall C. J. Regulation of cell signalling by uPAR. Nature Rev. Mol. Cell. Biol. 11, 23-36 (2010
25. Bonnefoy A. & Legrand C. Proteolysis of subendothelial adhesive glycoproteins (fibronectin thrombospondin and von Willebrand factor) by plasmin leukocyte cathepsin G, and elastase. Thromb. Res. 98, 323-332 (2000
26. Giuffrida P., Biancheri P. & MacDonald T. T. Proteases and small intestinal barrier function in health and disease. Curr. Opin. Gastroenterol. 30, 147-153 (2014
27. Mohamed M. M. & Sloane B. F. Cysteine cathepsins: multifunctional enzymes in cancer. Nature Rev. Cancer 6, 764-775 (2006
28. Fonovic M. & Turk B. Cysteine cathepsins and extracellular matrix degradation. Biochim. Biophys. Acta 1840, 2560-2570 (2014
29. Uchimura K., et al. HSulf 2, an extracellular endoglucosamine-6 sulfatase selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF FGF 1, and SDF 1. BMC Biochem. 7, 2 (2006
30. Barker N., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007
31. Hasebe T., et al. Thyroid hormone-induced cell-cell interactions are required for the development of adult intestinal stem cells. Cell Biosci. 3, 18 (2013
32. Su Y., Shi Y., Stolow M. A. & Shi Y. B. Thyroid hormone induces apoptosis in primary cell cultures of tadpole intestine: cell type specificity and effects of extracellular matrix. J. Cell Biol. 139, 1533-1543 (1997
33. Patterton D., Hayes W. P. & Shi Y. B. Transcriptional activation of the matrix metalloproteinase gene stromelysin 3 coincides with thyroid hormone-induced cell death during frog metamorphosis. Dev. Biol. 167, 252-262 (1995
34. Ishizuya-Oka A., et al. Requirement for matrix metalloproteinase stromelysin 3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis. J. Cell Biol. 150, 1177-1188 (2000
35. Amano T., Kwak O., Fu L., Marshak A. & Shi Y. B. The matrix metalloproteinase stromelysin 3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain. Cell Res. 15, 150-159 (2005
36. Fujimoto K., Nakajima K. & Yaoita Y. Expression of matrix metalloproteinase genes in regressing or remodeling organs during amphibian metamorphosis. Dev. Growth Differ. 49, 131-143 (2007
37. Hasebe T., Hartman R., Fu L., Amano T. & Shi Y. B. Evidence for a cooperative role of gelatinase A and membrane type 1 matrix metalloproteinase during Xenopus laevis development. Mech. Dev. 124, 11-22 (2007
38. Simon-Assmann P., Kedinger M., De Arcangelis A., Rousseau V. & Simo P. Extracellular matrix components in intestinal development. Experientia 51, 883-900 (1995
39. Simon-Assmann P., Kedinger M. & Haffen K. Immunocytochemical localization of extracellular-matrix proteins in relation to rat intestinal morphogenesis. Differentiation 32, 59-66 (1986
40. Simon-Assmann P., Bouziges F., Freund J. N., Perrin-Schmitt F. & Kedinger M. Type IV collagen mRNA accumulates in the mesenchymal compartment at early stages of murine developing intestine. J. Cell Biol. 110, 849-857 (1990
41. Simon-Assmann P., et al. The laminins: role in intestinal morphogenesis and differentiation. Ann. NY Acad. Sci. 859, 46-64 (1998
42. Mahoney Z. X., Stappenbeck T. S. & Miner J. H. Laminin α 5 influences the architecture of the mouse small intestine mucosa. J. Cell Sci. 121, 2493-2502 (2008
43. Beaulieu J. F. Integrins and human intestinal cell functions. Front. Biosci. 4, D310-D321 (1999
44. Benoit Y. D., et al. Integrin α8β1 regulates adhesion migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism. Biol. Cell 101, 695-708 (2009
45. Benoit Y. D., et al. Integrin α8β1 confers anoikis susceptibility to human intestinal epithelial crypt cells. Biochem. Biophys. Res. Commun. 399, 434-439 (2010
46. Groulx J. F., et al. Collagen VI is a basement membrane component that regulates epithelial cell-fibronectin interactions. Matrix Biol. 30, 195-206 (2011
47. Henning S. J., et al. Meprin mRNA in rat intestine during normal and glucocorticoid-induced maturation: divergent patterns of expression of α and β subunits. FEBS Lett. 462, 368-372 (1999
48. Sato T. & Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190-1194 (2013
49. Kim H. Y. & Nelson C. M. Extracellular matrix and cytoskeletal dynamics during branching morphogenesis. Organogenesis 8, 56-64 (2012
50. Grobstein C. & Cohen J. Collagenase: effect on the morphogenesis of embryonic salivary epithelium in vitro. Science 150, 626-628 (1965
51. Nakanishi Y., Sugiura F., Kishi J. & Hayakawa T. Collagenase inhibitor stimulates cleft formation during early morphogenesis of mouse salivary gland. Dev. Biol. 113, 201-206 (1986
52. Keely P. J., Wu J. E. & Santoro S. A. The spatial and temporal expression of the α 2 β 1 integrin and its ligands collagen I, collagen IV and laminin suggest important roles in mouse mammary morphogenesis. Differentiation 59, 1-13 (1995
53. Brownfield D. G., et al. Patterned collagen fibers orient branching mammary epithelium through distinct signaling modules. Curr. Biol. 23, 703-709 (2013
54. Sakai T., Larsen M. & Yamada K. M. Fibronectin requirement in branching morphogenesis. Nature 423, 876-881 (2003
55. Onodera T., et al. Btbd7 regulates epithelial cell dynamics and branching morphogenesis. Science 329, 562-565 (2010
56. Daley W. P., Gulfo K. M., Sequeira S. J. & Larsen M. Identification of a mechanochemical checkpoint and negative feedback loop regulating branching morphogenesis. Dev. Biol. 336, 169-182 (2009
57. Daley W. P., Kohn J. M. & Larsen M. A focal adhesion protein-based mechanochemical checkpoint regulates cleft progression during branching morphogenesis. Dev. Dyn. 240, 2069-2083 (2011
58. Joo E. E. & Yamada K. M. MYPT1 regulates contractility and microtubule acetylation to modulate integrin adhesions and matrix assembly. Nature Commun. 5, 3510 (2014
59. Woodward T. L., Mienaltowski A. S., Modi R. R., Bennett J. M. & Haslam S. Z. Fibronectin and the α5β1 integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142, 3214-3222 (2001
60. Liu S., Young S. M. & Varisco B. M. Dynamic expression of chymotrypsin-like elastase 1 over the course of murine lung development. Am. J. Physiol. Lung Cell. Mol. Physiol. 306, L1104-L1116 (2014
61. Mammoto T., Jiang E., Jiang A. & Mammoto A. Extracellular matrix structure and tissue stiffness control postnatal lung development through the lipoprotein receptor-related protein 5/Tie2 signaling system. Am. J. Respir. Cell. Mol. Biol. 49, 1009-1018 (2013
62. Daley W. P. & Yamada K. M. ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr. Opin. Genet. Dev. 23, 408-414 (2013
63. Tan J., et al. Stromal matrix metalloproteinase 11 is involved in the mammary gland postnatal development. Oncogene 33, 4050-4059 (2013
64. Mori H., et al. Transmembrane/cytoplasmic rather than catalytic domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1. Development 140, 343-352 (2013
65. Wiseman B. S., et al. Site-specific inductive and inhibitory activities of MMP 2 and MMP 3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162, 1123-1133 (2003
66. Kessenbrock K., et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. Cell Stem Cell 13, 300-313 (2013
67. Correia A. L., Mori H., Chen E. I., Schmitt F. C. & Bissell M. J. The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β. Genes Dev. 27, 805-817 (2013
68. Goetz R. & Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nature Rev. Mol. Cell. Biol. 14, 166-180 (2013
69. Makarenkova H. P., et al. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2, ra55 (2009
70. Patel V. N., et al. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134, 4177-4186 (2007
71. Kim H. E., et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest. 106, 857-866 (2000
72. Bondeson J., Wainwright S., Hughes C. & Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin. Exp. Rheumatol. 26, 139-145 (2008
73. Echtermeyer F., et al. Syndecan 4 regulates ADAMTS 5 activation and cartilage breakdown in osteoarthritis. Nature Med. 15, 1072-1076 (2009
74. Martignetti J. A., et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nature Genet. 28, 261-265 (2001
75. El Serag H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127 (2011
76. Boyd N. F., Martin L. J., Yaffe M. J. & Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 13, 223 (2011
77. Biancheri P., et al. The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev. 25, 45-55 (2013
78. Verrecchia F., Chu M. L. & Mauviel A. Identification of novel TGF-β /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 276, 17058-17062 (2001
79. Wynn T. A. & Ramalingam T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Med. 18, 1028-1040 (2012
80. Giannandrea M. & Parks W. C. Diverse functions of matrix metalloproteinases during fibrosis. Dis. Model. Mech. 7, 193-203 (2014
81. Duffield J. S., Lupher M., Thannickal V. J. & Wynn T. A. Host responses in tissue repair and fibrosis. Annu. Rev. Pathol. 8, 241-276 (2013
82. McHedlidze T., et al. Interleukin-33 dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357-371 (2013
83. Bailey J. R., et al. IL 13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?. PLoS ONE 7, e52332 (2013
84. Clarke D. L., Carruthers A. M., Mustelin T. & Murray L. A. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogen. Tissue Repair 6, 20 (2013
85. Rieder F. The gut microbiome in intestinal fibrosis: environmental protector or provocateur?. Sci. Transl. Med. 5, 190ps10 (2013
86. Parker M. W., et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124, 1622-1635 (2014
87. Bhattacharyya S., et al. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci. Transl. Med. 6, 232ra50 (2014
88. Ding N., et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613 (2013
89. Chan M. F., et al. Protective effects of matrix metalloproteinase 12 following corneal injury. J. Cell Sci. 126, 3948-3960 (2013
90. Jiang D., et al. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan 4. J. Clin. Invest. 120, 2049-2057 (2010
91. Ding B. S., et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 505, 97-102 (2014
92. Atabai K., et al. Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. J. Clin. Invest. 119, 3713-3722 (2009
93. Bissell M. J. & Hines W. C. Why don't we get more cancer?. A proposed role of the microenvironment in restraining cancer progression. Nature Med. 17, 320-329 (2011
94. Tian X., et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499, 346-349 (2013
95. Lu P., Weaver V. M. & Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406 (2012
96. Burnier J. V., et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene 30, 3766-3783 (2011
97. Bergamaschi A., et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 214, 357-367 (2008
98. Poola I., et al. Identification of MMP 1 as a putative breast cancer predictive marker by global gene expression analysis. Nature Med. 11, 481-483 (2005
99. Paszek M. J., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254 (2005
100. Erler J. T., et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226 (2006
101. Levental K. R., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906 (2009
102. Erler J. T., et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009
103. Mouw J. K., et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nature Med. 20, 360-367 (2014
104. Valiathan R. R., Marco M., Leitinger B., Kleer C. G. & Fridman R. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 31, 295-321 (2012
105. Hidalgo-Carcedo C., et al. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nature Cell Biol. 13, 49-58 (2011
106. Zhang K., et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nature Cell Biol. 15, 677-687 (2013
107. Sengupta S., et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas up regulating mRNAs encoding extracellular matrix proteins. Proc. Natl Acad. Sci. USA 105, 5874-5878 (2008
108. Chou J., et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA 29b expression. Nature Cell Biol. 15, 201-213 (2013
109. Enerly E., et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS ONE 6, e16915 (2011
110. Cheresh D. A. & Stupack D. G. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27, 6285-6298 (2008
111. Saupe F., et al. Tenascin C downregulates wnt inhibitor dickkopf 1, promoting tumorigenesis in a neuroendocrine tumor model. Cell Rep. 5, 482-492 (2013
112. Mott J. D. & Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564 (2004
113. Burgess J. K. & Weckmann M. Matrikines and the lungs. Pharmacol. Ther. 134, 317-337 (2012
114. Sudhakar A., et al. Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin. J. Clin. Invest. 115, 2801-2810 (2005
115. Ray S. J., et al. The collagen binding α1β1 integrin VLA 1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20, 167-179 (2004
116. Song J., et al. Extracellular matrix of secondary lymphoid organs impacts on B cell fate and survival. Proc. Natl Acad. Sci. USA 110, E2915-E2924 (2013
117. Sorokin L. The impact of the extracellular matrix on inflammation. Nature Rev. Immunol. 10, 712-723 (2010
118. Monboisse J. C., Oudart J. B., Ramont L., Brassart- Pasco S. & Maquart F. X. Matrikines from basement membrane collagens: a new anti-cancer strategy. Biochim. Biophys. Acta 1840, 2589-2598 (2014
119. Gaggar A., et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J. Immunol. 180, 5662-5669 (2008
120. Weathington N. M., et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature Med. 12, 317-323 (2006
121. Muto J., et al. Hyaluronan digestion controls DC migration from the skin. J. Clin. Invest. 124, 1309-1319 (2014
122. Salmon H., et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest. 122, 899-910 (2012
123. Kim S., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 (2009
124. Wolf K. & Friedl P. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. Trends Cell Biol. 21, 736-744 (2011
125. Tozluoglu M., et al. Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nature Cell Biol. 15, 751-762 (2013
126. Bergers G., et al. Matrix metalloproteinase 9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2, 737-744 (2000
127. Lee S., Jilani S. M., Nikolova G. V., Carpizo D. & Iruela-Arispe M. L. Processing of VEGF A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691 (2005
128. Ferrara N. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol. Biol. Cell 21, 687-690 (2010
129. Chen T. T., et al. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J. Cell Biol. 188, 595-609 (2010
130. Phillips J. J., et al. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma. J. Clin. Invest. 122, 911-922 (2012
131. Grafe I., et al. Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. Nature Med. 20, 670-675 (2014
132. Alcaraz L. B., et al. Tenascin X promotes epithelial-to mesenchymal transition by activating latent TGF-β. J. Cell Biol. 205, 409-428 (2014
133. Watt F. M. & Huck W. T. Role of the extracellular matrix in regulating stem cell fate. Nature Rev. Mol. Cell. Biol. 14, 467-473 (2013
134. Debnath J. & Brugge J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nature Rev. Cancer 5, 675-688 (2005
135. Ridky T. W., Chow J. M., Wong D. J. & Khavari P. A. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nature Med. 16, 1450-1455 (2010
136. Yurchenco P. D. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb. Perspect. Biol. 3, a004911 (2011
137. Seif-Naraghi S. B., et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med. 5, 173ra25 (2013
138. Lee B., et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J. Clin. Invest. 121, 3005-3023 (2011
139. Martino M. M., et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343, 885-888 (2014
140. Giger R. J., Hollis E. R. 2nd & Tuszynski M. H. Guidance molecules in axon regeneration. Cold Spring Harb. Perspect. Biol. 2, a001867 (2010
141. Busch S. A. & Silver J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 17, 120-127 (2007
142. Alilain W. J., Horn K. P., Hu H., Dick T. E. & Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 475, 196-200 (2011
143. Back S. A., et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nature Med. 11, 966-972 (2005
144. Barry-Hamilton V., et al. Allosteric inhibition of lysyl oxidase-like 2 impedes the development of a pathologic microenvironment. Nature Med. 16, 1009-1017 (2010
145. Coussens L. M., Fingleton B. & Matrisian L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392 (2002
146. Devy L. & Dransfield D. T. New strategies for the next generation of matrix-metalloproteinase inhibitors: selectively targeting membrane-anchored MMPs with therapeutic antibodies. Biochem. Res. Int. 2011, 191670 (2011
147. Zeisberg M., et al. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med. 3, e100 (2006
148. Junttila M. R. & de Sauvage F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346-354 (2013
149. Miyamoto H., et al. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 28, 38-44 (2004
150. Sethi T., et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med. 5, 662-668 (1999
151. Eke I., Storch K., Krause M. & Cordes N. Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis. Cancer Res. 73, 5869-5879 (2013
152. Henderson N. C., et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nature Med. 19, 1617-1624 (2013
153. Psaila B. & Lyden D. The metastatic niche: adapting the foreign soil. Nature Rev. Cancer 9, 285-293 (2009
154. Kaplan R. N., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005
155. Oskarsson T., et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nature Med. 17, 867-874 (2011
156. Malanchi I., et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2011
157. Ghajar C. M., et al. The perivascular niche regulates breast tumour dormancy. Nature Cell Biol. 15, 807-817 (2013
158. Pietras A., et al. Osteopontin CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell 14, 357-369 (2014
159. Reticker-Flynn N. E., et al. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nature Commun. 3, 1122 (2012
160. Kessenbrock K., Plaks V. & Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67 (2010
161. Ishizuya-Oka A. & Hasebe T. Establishment of intestinal stem cell niche during amphibian metamorphosis. Curr. Top. Dev. Biol. 103, 305-327 (2013